Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: Design and rationale of the SYNERGY Library

American Heart Journal

Volumn 148, Issue 2, 2004, Pages 269-276

  Petersen, John L ^a   Mahaffey, Kenneth W ^a,j   Becker, Richard C ^b   Goodman, Shaun G ^c   Kleiman, Neal S ^d   Marian, A J ^d   Stone, Gregg W ^e   Lansky, Alexandra J ^e   Lincoff, A Michael ^f   Hazen, Stanley L ^f   Nessel, Christopher C ^g   Toro Figueroa, Luis ^g   Tate, Lynn ^a   Reist, Craig J ^a   Cohen, Marc ^h   Califf, Robert M ^a   Ferguson, James J ⁱ  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g SANOFI   (France)

^h NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

ⁱ ST LUKE S EPISCOPAL HOSPITAL   (United States)

^j DUKE CLINICAL RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; ELECTROCARDIOGRAM; GENETICS; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANGINA, UNSTABLE; ANTICOAGULANTS; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; ENOXAPARIN; HEPARIN; HUMANS; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RISK FACTORS;

EID: 4143068070     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.03.022     Document Type: Article

References (29)

1. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med. 340:1999;115-126
2. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 322:1993;1615-1622
3. Goodman S.G., Barr A., Sobtuchouk A., et al. Low-molecular-weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction the Canadian ESSENCE ST segment monitoring substudy. J Am Coll Cardiol. 36:2000;1507-1513
4. Lindahl B., Toss H., Siegbahn A., et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 343:2000;1139-1147
5. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes a TIMI 11A substudy. J Am Coll Cardiol. 1998;1460-1465
6. Bray P.F., Cannon C.P., Goldschmidt-Clermont P., et al. The platelet PlA2 and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol. 88:2001;347-352
7. SYNERGY Investigators. The SYNERGY Trial study design and rationale. Am Heart J. 143:2002;952-960
8. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction, 2002. Circulation. 106:2002;1893-1900
9. Fleiss J.L. Statistical methods for rates and proportions. 1981;217-234 Wiley, New York
10. Zhang R., Shen Z., Nauseef W.M., et al. The role of myeloperoxidase in the initiation of lipid peroxidation in plasma as studied in neutrophils isolated from myeloperoxidase deficient subjects. Blood. 99:2002;1802-1810
11. Zhang R., Brennan M.L., Shen Z., et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem. 277:2002;46116-46122
12. Brennan M.L., Wu W., Fu X., et al. A tale of two controversies i) Defining the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase deficient mice; and ii) Defining the nature of peroxidase-generated reactive nitrogen species. J Biol Chem. 277:2002;17415-17427
13. Shishehbor M.H., Aviles R.J., Brennan M.L., et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA. 289:2003;1675-1680
14. Shishehbor M.H., Brennan M.L., Aviles R.J., et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation. 108:2003;426-431
15. Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 286:2001;2136-2142
16. Brennan ML, Penn MS, van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595-604
17. Orita M., Iwahana H., Kanazawa H., et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 86:1989;2766-2770
18. Ravnik-Glavac M., Glavac D., Dean M. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum Mol Genet. 3:1994;801-807
19. Saiki R.K., Felfand D.H., Stoffel S., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA Polymererase. Science. 239:1988;487-491
20. Coulter S.A., Cannon C.P., Ault K.A., et al. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction results from TIMI 14. Circulation. 101:2000;2690-2695
21. Gilchrist I.C., Berkowitz S.D., Thompson T.D., et al. Heparin dosing and outcome in acute coronary syndromes the GUSTO-IIb experience. Am Heart J. 144:2002;73-80
22. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 101:2000;125-132
23. Boersma E., Pieper K., Steyerberg E., et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients. Circulation. 101:2000;2557-2567
24. Antman E., Cohen M., Bernink P., et al. The TIMI risk score for unstable angina/non-ST-elevation MI a method for prognostication and therapeutic decision-making. JAMA. 284:2000;835-842
25. Kaul P., Fu Y., Chang W., et al. Prognostic values of ST segment depression in acute coronary syndromes insights from PARAGON-B applied to GUSTO-IIb. J Am Coll Cardiol. 38:2001;64-71
26. Kaul P., Newby L., Fu Y., et al. Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients. J Am Coll Cardiol. 41:2003;371-380
27. Libby P. Coronary artery injury and the biology of atherosclerosis inflammation, thrombosis, and stabilization. Am J Cardiol. 86:2000;3J-8J
28. Heidenreich P.A., Alloggiamento T., Melsop K., et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes a meta-analysis. J Am Coll Cardiol. 38:2001;478-485
29. Holmvang L., Hasbak P., Clemmensen P., et al. Differences between local investigator and core-laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non-Q myocardial infarction a thrombin inhibition in myocardial ischemia (TRIM) substudy. J Electrocardiol. 31:1998;S126-127